Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 118 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1171 10.1 months Metastatic colorectal cancer 4 Chemotherapy
Monash University Australia 1/2011
Treatment Details: Patients: This study involved patients with metastatic colorectal cancer who had received prior chemotherapy. Patients were divided into two separate treatment groups. Group A consisted o
 
1172 10.0 months Relapsed melanoma, recurrent melanoma 5 Biologic therapy
University of Pittsburgh Cancer Institute United States 2/2010
Treatment Details: Patients: This phase II study involved 251 patients with relapsed or refractory melanoma. The median age was 53 years and 60% were male. Treatment: Patients were treated with the biolo
 
1173 10.0 months Metastatic melanoma 5 Biologic therapy
Immunotherapy
Dana–Farber Cancer Institute United States 8/2010
Treatment Details: Patients: This study involved metastatic melanoma patients that were positive for HLA-A*0201, which is a specific version of a gene involved in the immune response. Patients were divided i
 
1174 10.0 months NSCLC 5 Chemotherapy
Errikos Dunant Hospital Greece 11/2010
Treatment Details: Patients: This phase 3 study involved patients with non-small-cell lung cancer. Patients were divided into two separate treatment groups. In group A, there were 114 patients, 104 of whom
 
1175 10.0 months Advanced hepatocellular carcinoma 4 Biologic therapy
National Cancer Center Korea 3/2011
Treatment Details: Patients: This study consisted of 55 patients with advanced hepatocellular carcinoma. The median patient age was 60 years (range of 27-80) and 89.1% were male. Treatment: Patients were
 
1176 10.0 months NSCLC 4 Chemotherapy
Chinese PLA General Hospital China 4/2010
Treatment Details: Patients: This study involved 53 patients with non-small cell lung cancer (NSCLC) who had received previous platinum-based therapy. The median patient age was 52 years and 73.6% were male.
 
1177 10.0 months Malignant Pleural Mesothelioma 4 Chemotherapy
Cleveland Clinic Foundation United States 5/2008
Treatment Details: Patients: This study involved 50 patients with unresectable malignant pleural mesothelioma. The median age was 69 (range of 36-80) and 88% were male. Patients had not received any prior c
 
1178 10.0 months Advanced NSCLC 5 Biologic therapy
Chemotherapy
Doce de Octobre University Hospital Spain 3/2006
Treatment Details: Patients: This Phase III study involved 670 patients with advanced non-small-cell lung cancer. None of the patients had received treatment before the study. The patients were randomly divi
 
1179 10.0 months Advanced NSCLC 4 Chemotherapy
University Hospital Sweden 11/2005
Treatment Details: Patients: This Phase III study involved a total of 325 patients. Patients were divided into two groups: Group A had 169 patients and Group B had 156 patients. The median age for patients i
 
1180 10.0 months advanced melanoma 3 Immunotherapy
Virginia Commonwealth University United States 1/2006
Treatment Details: Patients: This phase 2 study involved 26 patients with advanced cutaneous melanoma (all with the Human Leukocyte Antigen genotype). Treatment: Treatment consisted of immunotherapy - m
 
Page 118 of 187  | Previous Page  | Next Page